New Vital Signs
New Vital Signs, Inc. develops wearable sensor devices for non-invasive medical measurements.
Founded
2015New Vital Signs, Inc. develops wearable sensor devices for non-invasive medical measurements.
New Vital Signs, Inc. was founded with the mission to revolutionize patient monitoring through innovative, non-invasive wearable sensor technology. The company's core product, Dynamic Respiratory Impedance Volume Evaluation (DRIVE), measures changes in bioimpedance of a patient's limb as they breathe, providing doctors with critical insights into fluid status or intravascular volume. This technology aims to enable earlier intervention and improve patient outcomes by detecting physiological changes sooner than traditional vital signs.
Notable affiliated individuals include experts in biomedical engineering and healthcare innovation, though specific names are not provided. The company has attracted interest from investors focused on cutting-edge medical technologies. Key achievements include the development and ongoing refinement of the DRIVE device, positioning New Vital Signs as a leader in the field of advanced patient monitoring. The overall impact of their work promises significant advancements in early detection and management of serious illnesses, potentially transforming patient care standards globally.
Companies similar to New Vital Signs include RTM Vital Signs, Impact Vitals, Vital Sensors and Praesidium.
New Vital Signs was founded in 2015.
New Vital Signs' headquarters is located in Ann Arbor, MI, US.
New Vital Signs' most recent funding round was for $1M (USD) in September 2016.
As of Sep 15, 2016, New Vital Signs has raised a total of $1M (USD).
New Vital Signs has 6 employees as of Feb 5, 2024.
Vital Sensors
